DYN earnings date and last-quarter result: next report 2026-07-27, last quarter beat, P/E -7.21. Updated 2026-07-23.
Dyne Therapeutics (DYN) Research Hub
Dyne Therapeutics (DYN) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 15.72 USD (+0.64%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -7.21, market cap 3.71B. This hub links to the full technical, earnings and options research available for DYN.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 15.72 USD (+0.64%) |
| 52-week range | 14.13 USD – 27.13 USD |
| Trend regime | Range |
| 14-day RSI | 52.3 (Neutral) |
| Trailing P/E | -7.21 |
| Market cap | 3.71B |
| Dividend yield | 0.00% |
| Next earnings | 2026-07-27 |
Available research for DYN
Covered Call on DYN: how it works, illustrative setup around the real 15.72 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on DYN: how it works, illustrative setup around the real 15.72 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on DYN: how it works, illustrative setup around the real 15.72 USD price, max profit/loss, breakeven and when to use it. Educational.
DYN technical analysis: range, last 15.72 USD, RSI 52.3, 52w range 14.13 USD–27.13 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is DYN in?
Dyne Therapeutics (DYN) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is DYN in an uptrend or downtrend?
As of 2026-10-26, DYN is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is DYN's trailing P/E ratio?
DYN's trailing P/E is -7.21, with a market cap of 3.71B. See the earnings research page for full valuation detail.
When does DYN next report earnings?
DYN is next scheduled to report earnings on 2026-07-27.